|
Dr. Smith brings to Labopharm more than 12 years experience directing research and development programs for growth-oriented pharmaceutical companies. Damon has taken three products from development through to commercialization. Most recently, he was Director of Research at Montreal-based ConjuChem Inc., where he was responsible for all research and early development operations, including the management of both internal and external collaborative research programs. Prior to joining ConjuChem, Dr. Smith was Executive Director of Development at Protherics Ltd. and Director of Development at Therapeutics Antibodies Inc., both of which are based in the United Kingdom. Dr. Smith holds a B.Sc. and a PhD. in biological chemistry from the University of Essex, United Kingdom. | 